Dr. Lina Alharbi is a PharmD graduate from King Saud bin Abdulaziz University for Health Sciences, with a strong academic foundation in clinical pharmacy, research, and pharmaceutical sciences. During her training at KSAU, she gained experience across multiple clinical pharmacy rotations, participated in academic discussions, journal clubs, and research presentations, and developed strong interests in infectious diseases, antimicrobial therapy, and drug delivery systems. She also served as an Infectious Disease Research Assistant at King Abdullah International Medical Research Center, where she worked on phage therapy, molecular biology techniques, PCR, gel electrophoresis, DNA quantification, and human cell line research. Her research contributions include projects related to ciprofloxacin-chitosan nanoparticles, multidrug-resistant bacteria, colistin therapy, and antimicrobial outcomes. Her research interests include antimicrobial resistance, infectious diseases, nanotechnology-based drug delivery, and improving healthcare through evidence-based research.